Thiogenesis Therapeutics, Corp.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-096/9/26 | New | $28,964 | $28,964 | Equity Only | 06b | SEC linkSEC |
| 2025-08-088/8/25 | New | $125,450 | Unknown | Equity Only | SEC linkSEC | |
| 2023-12-2012/20/23 | New | $252,281 | $252,281 | Equity Only | 06b | SEC linkSEC |
| 2022-11-2511/25/22 | New | $218,303 | $218,303 | Equity Only | 06b | SEC linkSEC |
| 2021-08-118/11/21 | New | $252,756 | Unknown | Equity Only | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Neil A. Johnson | Director, Executive |
| Hogan W. Mullally | Director |
| W. Hogan Mullally | Director |
| Brook G. Riggins | Director, Executive |
| Patrice Rioux | Director, Executive |
| Christopher Starr | Director |
| Kim Tsuchimoto | Director |
Industry: Biotechnology (See others in industry)
Address:
4 King Street West, Suite 401
Toronto, A6, M5H 1B6
Phone: (888) 223-9165
Toronto, A6, M5H 1B6
Phone: (888) 223-9165